RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ANIP
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

ANI Pharmaceuticals stock price up 0.201% on Wednesday
(Updated on Mar 27, 2024)

Buy or Hold candidate since Feb 14, 2024 Gain 24.22% PDF

The ANI Pharmaceuticals stock price gained 0.201% on the last trading day (Wednesday, 27th Mar 2024), rising from $69.55 to $69.69. During the last trading day the stock fluctuated 1.17% from a day low at $69.50 to a day high of $70.31. The price has risen in 7 of the last 10 days and is up by 5.22% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 18 thousand more shares were traded than the day before. In total, 105 thousand shares were bought and sold for approximately $7.30 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 28.06% during the next 3 months and, with a 90% probability hold a price between $82.76 and $92.93 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ANIP Signals & Forecast

The ANI Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $69.11 and $63.33. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, January 30, 2024, and so far it has risen 28.58%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for ANI Pharmaceuticals stock

ANI Pharmaceuticals finds support from accumulated volume at $67.67 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.81 between high and low, or 1.17%. For the last week, the stock has had daily average volatility of 1.70%.

Our recommended stop-loss: $67.21 (-3.56%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 40 days ago.)

Trading Expectations (ANIP) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect ANI Pharmaceuticals to open at $69.83, and during the day (based on 14 day Average True Range), to move between $67.93 and $71.45, which gives a possible trading interval of +/-$1.76 (+/-2.52%) up or down from last closing price. If ANI Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 5.05% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $67.67, some $2.02 (2.90%) from the current price of $69.69, our system finds the risk reward attractive.

Is ANI Pharmaceuticals stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for ANI Pharmaceuticals stock to perform well in the short-term.

Current score: 4.225 Buy Candidate Unchanged

Predicted Opening Price for ANI Pharmaceuticals of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$69.83 ( 0.206%) $69.69

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ANIP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 70.64 1.37 %
R2 70.33 0.92 %
R1 70.14 0.650 %
Current price: 69.69
Support S1 69.52 -0.238 %
S2 69.33 -0.513 %
S3 69.02 -0.96 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 69.69
Support S1 67.67 -2.90%
S2 66.13 -5.11%
S3 66.00 -5.29%

FAQ

What is the symbol for ANI Pharmaceuticals Stock and on which exchange is it traded?
The symbol for ANI Pharmaceuticals is ANIP and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ANI Pharmaceuticals Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for ANI Pharmaceuticals stock to perform well in the short-term.

How to buy ANI Pharmaceuticals Stock?
ANI Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ANI Pharmaceuticals Stock.

What's the current price of ANI Pharmaceuticals Stock?
As of the end of day on the 2024-03-27, the price of an ANI Pharmaceuticals (ANIP) share was $69.69.

What is the 52-week high and low for ANI Pharmaceuticals Stock?
The 52-week high for ANI Pharmaceuticals Stock is $70.81 and the 52-week low is $36.99.

What is the market capitalization of ANI Pharmaceuticals Stock?
As of the 2024-03-27, the market capitalization of ANI Pharmaceuticals is 1.468B.

When is the next earnings date for ANI Pharmaceuticals?
The upcoming earnings date for ANI Pharmaceuticals is May 13, 2024.
Click to get the best stock tips daily for free!

About ANI Pharmaceuticals

ANI Pharmaceuticals ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development a... ANIP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT